Prosight Management LP 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 09:26 am Sale | 2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Prosight Management LP | 1,578,263 2.900% | -702,515 (-30.80%) | Filing |
| 2023-06-09 8:15 pm Purchase | 2023-05-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Prosight Management LP | 2,280,778 5.100% | 2,280,778 (New Position) | Filing |